BEROTEC

This brand name is authorized in Austria, Brazil, Estonia, Germany, Japan, Lithuania, Poland, South Africa.

Active ingredients

The drug BEROTEC contains one active pharmaceutical ingredient (API):

1	Fenoterol UNII RLI45Z99RB - FENOTEROL HYDROBROMIDE

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BEROTEC Inhaler	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AC04	Fenoterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	504500605135314, 504500606174313
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00495906, 00495912
EE	Ravimiamet	1044223
JP	医薬品医療機器総合機構	2252704G2020
LT	Valstybinė vaistų kontrolės tarnyba	1003787, 1069325, 1070362
PL	Rejestru Produktów Leczniczych	100009713, 100333201
ZA	Health Products Regulatory Authority	34/10.2.1/0367